These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 7396451)

  • 41. Teicoplanin and rifampicin singly and in combination in the treatment of experimental Staphylococcus epidermidis endocarditis in the rabbit model.
    Tuazon CU; Washburn D
    J Antimicrob Chemother; 1987 Aug; 20(2):233-7. PubMed ID: 2959643
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Comparative activities of vancomycin, tigecycline and rifampin in a rat model of methicillin-resistant Staphylococcus aureus osteomyelitis.
    Vergidis P; Schmidt-Malan SM; Mandrekar JN; Steckelberg JM; Patel R
    J Infect; 2015 Jun; 70(6):609-15. PubMed ID: 25576292
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Rifampicin-containing combinations are superior to combinations of vancomycin, linezolid and daptomycin against Staphylococcus aureus biofilm infection in vivo and in vitro.
    Jørgensen NP; Skovdal SM; Meyer RL; Dagnæs-Hansen F; Fuursted K; Petersen E
    Pathog Dis; 2016 Jun; 74(4):ftw019. PubMed ID: 27036412
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Randomized double-blinded trial of rifampin with either novobiocin or trimethoprim-sulfamethoxazole against methicillin-resistant Staphylococcus aureus colonization: prevention of antimicrobial resistance and effect of host factors on outcome.
    Walsh TJ; Standiford HC; Reboli AC; John JF; Mulligan ME; Ribner BS; Montgomerie JZ; Goetz MB; Mayhall CG; Rimland D
    Antimicrob Agents Chemother; 1993 Jun; 37(6):1334-42. PubMed ID: 8328783
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Rifampicin-containing antibiotic combinations in the treatment of difficult infections.
    Grüneberg RN; Emmerson AM; Ridgway GL
    J Antimicrob Chemother; 1984 Jun; 13 Suppl C():49-55. PubMed ID: 6469890
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Therapy of experimental staphylococcal mastitis in the mouse with cloxacillin and rifampicin, alone and in combination.
    Craven N; Anderson JC
    Res Vet Sci; 1981 Nov; 31(3):295-300. PubMed ID: 6919178
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Successful treatment of polymicrobial calcaneal osteomyelitis with telavancin, rifampin, and meropenem.
    Brinkman MB; Fan K; Shiveley RL; Van Anglen LJ
    Ann Pharmacother; 2012 Jun; 46(6):e15. PubMed ID: 22619476
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Comparative evaluation of cefazolin and clindamycin in the treatment of experimental Staphylococcus aureus osteomyelitis in rabbits.
    Mader JT; Adams K; Morrison L
    Antimicrob Agents Chemother; 1989 Oct; 33(10):1760-4. PubMed ID: 2589843
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Optimizing combination rifampin therapy for staphylococcal osteoarticular infections.
    Coiffier G; Albert JD; Arvieux C; Guggenbuhl P
    Joint Bone Spine; 2013 Jan; 80(1):11-7. PubMed ID: 23332140
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Teicoplanin alone or combined with rifampin compared with vancomycin for prophylaxis and treatment of experimental foreign body infection by methicillin-resistant Staphylococcus aureus.
    Schaad HJ; Chuard C; Vaudaux P; Waldvogel FA; Lew DP
    Antimicrob Agents Chemother; 1994 Aug; 38(8):1703-10. PubMed ID: 7985998
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effective treatment of cephalosporin-rifampin combinations against cryptic methicillin-resistant beta-lactamase-producing coagulase-negative staphylococcal experimental endocarditis.
    Brandt CM; Rouse MS; Tallan BM; Laue NW; Wilson WR; Steckelberg JM
    Antimicrob Agents Chemother; 1995 Aug; 39(8):1815-9. PubMed ID: 7486924
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Efficacies of various antimicrobial agents in treatment of Staphylococcus aureus abscesses and correlation with in vitro tests of antimicrobial activity and neutrophil killing.
    Bamberger DM; Fields MT; Herndon BL
    Antimicrob Agents Chemother; 1991 Nov; 35(11):2335-9. PubMed ID: 1804006
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Efficacy of short courses of oral novobiocin-rifampin in eradicating carrier state of methicillin-resistant Staphylococcus aureus and in vitro killing studies of clinical isolates.
    Arathoon EG; Hamilton JR; Hench CE; Stevens DA
    Antimicrob Agents Chemother; 1990 Sep; 34(9):1655-9. PubMed ID: 2285277
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Role of hypermutability on bacterial fitness and emergence of resistance in experimental osteomyelitis due to Staphylococcus aureus.
    Daurel C; Prunier AL; Chau F; Garry L; Leclercq R; Fantin B
    FEMS Immunol Med Microbiol; 2007 Nov; 51(2):344-9. PubMed ID: 17714489
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Attempts to eradicate methicillin-resistant Staphylococcus aureus colonization with the use of trimethoprim-sulfamethoxazole, rifampin, and bacitracin.
    Roccaforte JS; Bittner MJ; Stumpf CA; Preheim LC
    Am J Infect Control; 1988 Aug; 16(4):141-6. PubMed ID: 3263821
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Penetration of parenterally administered rifampicin into bone tissue.
    Roth B
    Chemotherapy; 1984; 30(6):358-65. PubMed ID: 6518835
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Treatment of experimental foreign body infection caused by methicillin-resistant Staphylococcus aureus.
    Lucet JC; Herrmann M; Rohner P; Auckenthaler R; Waldvogel FA; Lew DP
    Antimicrob Agents Chemother; 1990 Dec; 34(12):2312-7. PubMed ID: 2128441
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Efficacy of daptomycin in experimental endocarditis due to methicillin-resistant Staphylococcus aureus.
    Sakoulas G; Eliopoulos GM; Alder J; Eliopoulos CT
    Antimicrob Agents Chemother; 2003 May; 47(5):1714-8. PubMed ID: 12709345
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Oral rifampin for eradication of Staphylococcus aureus carriage from healthy and sick populations: a systematic review of the evidence from comparative trials.
    Falagas ME; Bliziotis IA; Fragoulis KN
    Am J Infect Control; 2007 Mar; 35(2):106-14. PubMed ID: 17327190
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Successful therapy of experimental chronic foreign-body infection due to methicillin-resistant Staphylococcus aureus by antimicrobial combinations.
    Chuard C; Herrmann M; Vaudaux P; Waldvogel FA; Lew DP
    Antimicrob Agents Chemother; 1991 Dec; 35(12):2611-6. PubMed ID: 1810196
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.